MyMD Pharmaceuticals Inc (MYMD)

[knuts4oe]

The recent news (8/10/21) of the Oravax vaccine in pill form soon to be tested on non-vaccinated citizens of Isreal to determine its effectiveness in producing antibodies was picked up by news agencies around the world.
A number of sources lauded the Oramed/Premas development as a breakthrough of blockbuster proportions, which has resulted in the Board of Directors of MyMD to consider spinning off their shares of Oravax to existing shareholders. Were this to be the case, if said spinoff were based on the current circumstances, MyMD (Florida) shareholders would receive 80% of those shares, and MyMD (Akers) 20%, while it was Akers that brought the Premas vaccine to the merger table.
This unfairness might require an adjustment in the normal spinoff procedure, for example allowing MyMD (Akers) shareholders to receive 1 share of Oravax for each 100 shares of MyMD owned, but only allowing MyMD (Florida) shareholders to receive 1 share of Oravax for each 400 shares of MyMD owned.